---
title: Total Cardiac Intelligence
---

[Skip to content](https://insights.patentvest.com#main-content)

[![](https://insights.patentvest.com/hubfs/Artboard%201.svg)](https://www.patentvest.com/)

- [Why PatentVest](https://www.patentvest.com/why-patentvest/)
- [Our Solution](https://www.patentvest.com/our-solution/)
- [About Us](https://www.patentvest.com/about-us/)
  
  Show submenu for About Us 
  
    - [About PatentVest](https://www.patentvest.com/about-us/)
    - [Our Team](https://www.patentvest.com/about-us/our-team/)
    - [Our Track Record](https://www.patentvest.com/about-us/our-track-record/)
- [Contact Us](https://www.patentvest.com/contact-us/)

Open main navigation

Close main navigation

- [Why PatentVest](https://www.patentvest.com/why-patentvest/)
- [Our Solution](https://www.patentvest.com/our-solution/)
- [About Us](https://www.patentvest.com/about-us/)
  
  Show submenu for About Us 
  
    - [About PatentVest](https://www.patentvest.com/about-us/)
    - [Our Team](https://www.patentvest.com/about-us/our-team/)
    - [Our Track Record](https://www.patentvest.com/about-us/our-track-record/)
- [Contact Us](https://www.patentvest.com/contact-us/)

## PATENTVEST PULSE

## The State of Cardiac Technology

A Strategic and IP-Centric Analysis of the Cardiac Diagnostics Ecosystem

This PatentVest Pulse Report maps the convergence of consumer wearables, ambulatory monitors, and traditional 12-lead clinical systems - revealing who is leading, who is catching up, and where the next breakthroughs will occur.

Based on PatentVest’s proprietary analysis, this report identifies the emerging companies shaping the $133 billion cardiac diagnostics market.

October 28, 2025

### To access this report, please complete the form below

Cardiac diagnostics are undergoing a once-in-a-generation shift. The tools that once lived exclusively inside hospitals are moving into everyday life - transforming how heart disease is detected, managed, and prevented.

Key Insights

- Apple, Samsung, Google, Fitbit, Whoop, Oura, Withings, Garmin, Zepp Health, and Masimo have brought heart-rate tracking and single-lead ECGs to hundreds of millions of wrists. Yet all remain confined to rhythm screening - unable to detect ischemia or match 12-lead diagnostic accuracy. 
- Companies such as HeartBeam, iRhythm, and AliveCor are pushing beyond rhythm tracking toward diagnostic-grade performance. HeartBeam stands out as the first to enable clinical-grade ischemia detection tool in credit-card-sized form factor - offering the first credible pathway toward total cardiac intelligence.
- PatentVest’s analysis of 581 patent families across 243 organizations shows traditional device makers like Philips, GE Healthcare, and Nihon Kohden being challenged by next-generation innovators including HeartBeam, AliveCor, Mayo Clinic, Tempus AI, Eko Health, Anumana, Medical AI Co., and Bodyfriend Co.

[![](https://insights.patentvest.com/hubfs/Artboard%201.svg)](https://www.patentvest.com/)

[LinkedIn](https://www.linkedin.com/company/patentvest-inc.)